| For: | Jiang L, Jiang LS, Cheng NS, Yan LN. Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation. World J Gastroenterol 2009; 15(20): 2489-2499 [PMID: 19468999 DOI: 10.3748/wjg.15.2489] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i20/2489.htm |
| Number | Citing Articles |
| 1 |
Y. Li, Y. Shi, J. Chen, B. Cai, B. Ying, L. Wang. Association of polymorphisms in interleukin‐18 and interleukin‐28B with Hepatitis B recurrence after liver transplantation in Chinese Han population. International Journal of Immunogenetics 2012; 39(4) doi: 10.1111/j.1744-313X.2012.01097.x
|
| 2 |
Elisabete Arrese, Miren Basaras, Sonia Blanco, Pablo Ruiz, Ramόn Cisterna. Evolution of hepatitis B virus during long-term therapy in patients with chronic hepatitis B . Annals of Hepatology 2011; 10(4) doi: 10.1016/S1665-2681(19)31509-1
|
| 3 |
Zhuo-Lun Song, Yu-Jun Cui, Wei-Ping Zheng, Da-Hong Teng, Hong Zheng. Application of nucleoside analogues to liver transplant recipients with hepatitis B. World Journal of Gastroenterology 2015; 21(42): 12091-12100 doi: 10.3748/wjg.v21.i42.12091
|
| 4 |
Claudia Della Corte, Valerio Nobili, Donatella Comparcola, Francesca Cainelli, Sandro Vento. Management of chronic hepatitis B in children: An unresolved issue. Journal of Gastroenterology and Hepatology 2014; 29(5) doi: 10.1111/jgh.12550
|
| 5 |
Payam Dindoost, Seyed Mohammad Jazayeri, Seyed Moayed Alavian. Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update. Hepatitis Monthly 2012; 12(3) doi: 10.5812/hepatmon.5124
|
| 6 |
Corinne Buchanan, Tram T. Tran. Current Status of Liver Transplantation for Hepatitis B Virus. Clinics in Liver Disease 2011; 15(4) doi: 10.1016/j.cld.2011.08.011
|
| 7 |
H. Miyaaki, Y. Tamada, K. Hayashi, N. Taura, S. Miuma, H. Shibata, A. Soyama, M. Hidaka, M. Takatsuki, S. Eguchi, K. Nakao. Recurrent Hepatitis B and D Virus Infection in a Liver Transplant Recipient. Transplantation Proceedings 2017; 49(1) doi: 10.1016/j.transproceed.2016.11.010
|
| 8 |
Arianeb Mehrabi, Majid Esmaeilzadeh, Hamidreza Fonouni, Mohammadreza Hafezi, Nuh N. Rahbari, Mohammad Golriz, Ali Majlesara, Morva Tahmasbi Rad, Mahmoud Sadeghi, Jan Schmidt, Tom M. Ganten. The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation. Langenbeck's Archives of Surgery 2012; 397(5) doi: 10.1007/s00423-011-0795-6
|
| 9 |
E. Magiorkinis, D. Paraskevis, I.D. Pavlopoulou, M. Kantzanou, C. Haida, A. Hatzakis, I.N. Boletis. Renal transplantation from hepatitis B surface antigen (HBsAg)‐positive donors to HBsAg‐negative recipients: a case of post‐transplant fulminant hepatitis associated with an extensively mutated hepatitis B virus strain and review of the current literature. Transplant Infectious Disease 2013; 15(4) doi: 10.1111/tid.12094
|
| 10 |
Lucas Carvalho Dantas, Tércio Genzini, Marcelo Perosa de Miranda, Regina Gomes dos Santos, Nilton Ghiotti de Siqueira, Judith Weirich, Cirley Maria de Oliveira Lobato. Liver transplantation in a patient with hepatitis B, C and D coinfection associated with hepatocellular carcinoma: a management strategy for a rare condition. Case report. Sao Paulo Medical Journal 2015; 133(6) doi: 10.1590/1516-3180.2015.8881501
|
| 11 |
Jian Yong Lei, Wen Tao Wang, Lu Nan Yan. Hangzhou criteria for liver transplantation in hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 2014; 26(2) doi: 10.1097/MEG.0b013e3283652b66
|
| 12 |
Ming-Tsung Lin, Yi-Hao Yen, Ming-Chao Tsai, Po-Lin Tseng, Kuo-Chin Chang, Cheng-Kun Wu, Tsung-Hui Hu, Seung Up Kim. Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice. PLOS ONE 2016; 11(11) doi: 10.1371/journal.pone.0165416
|
| 13 |
|
| 14 |
Ali Yahyazadeh, Susanne Beckebaum, Vito Cicinnati, Christian Klein, Andreas Paul, Andreas Pascher, Ruth Neuhaus. Efficacy and safety of subcutaneous human HBV-immunoglobulin (Zutectra®) in liver transplantation: an open, prospective, single-arm phase III study. Transplant International 2011; 24(5) doi: 10.1111/j.1432-2277.2011.01222.x
|
| 15 |
Yanyi Ren, Zhaozhe Liu, Zhenyu Ding, Xiaodong Xie. Autologous cytokine-induced killer cells in equal to liver protectant in a patient with metastatic rectal cancer. The Chinese-German Journal of Clinical Oncology 2013; 12(7) doi: 10.1007/s10330-013-1174-2
|
| 16 |
Amir Kasraianfard, Kymberly D. Watt, Lance Lindberg, Sophoclis Alexopoulos, Nima Rezaei. HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation. International Reviews of Immunology 2014; doi: 10.3109/08830185.2014.921160
|